[go: up one dir, main page]

AU2003245536A1 - Cancer-linked gene as target for chemotherapy - Google Patents

Cancer-linked gene as target for chemotherapy

Info

Publication number
AU2003245536A1
AU2003245536A1 AU2003245536A AU2003245536A AU2003245536A1 AU 2003245536 A1 AU2003245536 A1 AU 2003245536A1 AU 2003245536 A AU2003245536 A AU 2003245536A AU 2003245536 A AU2003245536 A AU 2003245536A AU 2003245536 A1 AU2003245536 A1 AU 2003245536A1
Authority
AU
Australia
Prior art keywords
chemotherapy
cancer
target
linked gene
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003245536A
Other languages
English (en)
Other versions
AU2003245536A8 (en
Inventor
Reinhard Ebner
Stephen Horrigan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clinical Data Inc
Original Assignee
Avalon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avalon Pharmaceuticals Inc filed Critical Avalon Pharmaceuticals Inc
Publication of AU2003245536A1 publication Critical patent/AU2003245536A1/en
Publication of AU2003245536A8 publication Critical patent/AU2003245536A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003245536A 2002-06-10 2003-06-09 Cancer-linked gene as target for chemotherapy Abandoned AU2003245536A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38747602P 2002-06-10 2002-06-10
US60/387,476 2002-06-10
PCT/US2003/019063 WO2003104436A2 (fr) 2002-06-10 2003-06-09 Gène associé au cancer en tant que cible pour la chimiothérapie

Publications (2)

Publication Number Publication Date
AU2003245536A1 true AU2003245536A1 (en) 2003-12-22
AU2003245536A8 AU2003245536A8 (en) 2003-12-22

Family

ID=29736321

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003245536A Abandoned AU2003245536A1 (en) 2002-06-10 2003-06-09 Cancer-linked gene as target for chemotherapy

Country Status (2)

Country Link
AU (1) AU2003245536A1 (fr)
WO (1) WO2003104436A2 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1230360A4 (fr) * 1999-11-09 2003-04-02 Human Genome Sciences Inc 15 proteines secretees humaines

Also Published As

Publication number Publication date
WO2003104436A2 (fr) 2003-12-18
AU2003245536A8 (en) 2003-12-22
WO2003104436A3 (fr) 2004-06-10

Similar Documents

Publication Publication Date Title
AU2003245441A1 (en) Cancer-linked gene as target for chemotherapy
AU2003229294A1 (en) Cancer-linked gene as target for chemotherapy
AU2003239969A1 (en) Cancer-linked gene as target for chemotherapy
EP1576111A3 (fr) Gene lie au cancer servant de cible en chimiotherapie
EP1575492A3 (fr) Gene lie au cancer comme cible de chimiotherapie
AU2003249691A1 (en) Cancer-linked gene as target for chemotherapy
AU2003213743A1 (en) Cancer-linked gene as target for chemotherapy
AU2003253677A1 (en) Cancer-linked gene as target for chemotherapy
AU2003229293A1 (en) Cancer-linked gene as target for chemotherapy
AU2003238897A1 (en) Cancer-linked gene as target for chemotherapy
AU2003230611A1 (en) Cancer-linked gene as target for chemotherapy
AU2003247564A1 (en) Cancer-linked gene as target for chemotherapy
AU2003218014A1 (en) Cancer-linked gene as target for chemotherapy
AU2003237414A1 (en) Cancer-linked gene as target for chemotherapy
AU2003241456A1 (en) Cancer-linked gene as target for chemotherapy
AU2003213672A1 (en) Cancer-linked gene as target for chemotherapy
AU2003243440A1 (en) Cancer-linked gene as target for chemotherapy
AU2003245448A1 (en) Cancer-linked gene as target for chemotherapy
AU2003276643A1 (en) Cancer-linked gene as target for chemotherapy
AU2003240572A1 (en) Cancer-linked gene as target for chemotherapy
AU2003241455A1 (en) Cancer-linked gene as target for chemotherapy
AU2003245536A1 (en) Cancer-linked gene as target for chemotherapy
AU2003251515A1 (en) Cancer-linked gene as target for chemotherapy
AU2003248528A1 (en) Cancer-linked gene as target for chemotherapy

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase